A former cancer researcher, Lucy brings a strong technical background to her work with organizations across the life-sciences sector. Since joining McKinsey, she has partnered with CEOs and top teams at leading organizations across North America, Europe, and Asia. She currently co-leads the McKinsey global regulatory affairs group with the Pharmaceutical & Medical Products Practice.
Whether working with established pharmaceutical companies to hone R&D investments and optimize commercial operations, or advising healthcare providers on growth and innovation, Lucy takes a strategic, long-term perspective. Given her background in oncology, she often works with clients in the optimization of asset-development and commercialization plans as well as improving specialized-care delivery approaches.
Before joining McKinsey, Lucy was a research fellow at Memorial Sloan-Kettering Cancer Center, where she was involved in the development of novel treatments for solid tumors. She was also a Howard Hughes Medical Institute research fellow at Harvard University while completing her doctoral studies. She is co-inventor on multiple patents and has published in peer-reviewed journals.
